Minneslate Logo

HF2906 (Legislative Session 94 (2025-2026))

Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory council established; and money appropriated.

AI Generated Summary

Purpose of the Bill

The bill aims to create a regulated program in Minnesota for the therapeutic use of psilocybin, a psychoactive compound found in certain mushrooms. This program is intended for individuals above the age of 21 with qualifying medical conditions, offering a legal framework for accessing psilocybin in a safe and therapeutic manner.

Main Provisions

  • Psilocybin Therapeutic Use Program: Establishment of a program under the Minnesota Department of Health for the administration and use of psilocybin through supervised sessions, addressing patient safety and harm reduction.
  • Eligibility and Enrollment: Individuals must be over 21, have a qualifying medical condition, and pass a health screening to enroll in the program starting January 1, 2027.
  • Designation and Cultivation: Registered patients can personally cultivate psilocybin or designate someone to cultivate on their behalf. Specific rules govern the amount and safety protocols of cultivation.
  • Facilitation and Supervision: Trained registered facilitators will oversee psilocybin administration sessions and are required to lead preparation and integration sessions.
  • Regulation and Rulemaking: The Health and Agriculture Commissioners will set rules concerning qualifying conditions, cultivation limits, and facilitator qualifications.

Significant Changes to Existing Law

  • Legal Protections: The bill includes protections against civil and criminal liabilities for participants, facilitators, and public employees associated with the program. It also restricts law enforcement from accessing registry data.
  • Employment and Housing Protections: Protects registered patients and facilitators from discrimination in employment and housing based solely on their participation in the program.
  • Advisory Committee: Formation of a Psychedelic Medicine Advisory Committee to guide the program's development and ensure ongoing evaluation.

Relevant Terms

psilocybin, therapeutic use, registered facilitators, designated cultivators, harm reduction, patient safety, advisory committee, cultivation, eligibility criteria, health screening, rulemaking, legal protections, discrimination in housing and employment.

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
March 26, 2025HouseFloorActionIntroduction and first reading, referred toHealth Finance and Policy
March 31, 2025HouseFloorActionAuthor added

Citations

 
[
  {
    "analysis": {
      "added": [
        ""
      ],
      "removed": [
        ""
      ],
      "summary": "Definition of 'Motor Vehicle' relevant to the bill's context.",
      "modified": [
        "References for consistency with existing definitions."
      ]
    },
    "citation": "169A.03",
    "subdivision": "subdivision 15"
  },
  {
    "analysis": {
      "added": [
        ""
      ],
      "removed": [
        ""
      ],
      "summary": "Defines 'public school' concerning prohibited psilocybin possession locations.",
      "modified": [
        "Clarifies where psilocybin use and possession are restricted in relation to schools."
      ]
    },
    "citation": "120A.05",
    "subdivision": "subdivisions 9, 11, and 13"
  },
  {
    "analysis": {
      "added": [
        ""
      ],
      "removed": [
        ""
      ],
      "summary": "Includes charter schools in the definition relating to prohibited areas for psilocybin use.",
      "modified": [
        "Aligns with the statutory framework for Minnesota charter schools."
      ]
    },
    "citation": "124E",
    "subdivision": ""
  },
  {
    "analysis": {
      "added": [
        ""
      ],
      "removed": [
        ""
      ],
      "summary": "Makes psilocybin and related property not subject to forfeiture under specified sections.",
      "modified": [
        "Exempts psilocybin-related property from asset forfeiture laws."
      ]
    },
    "citation": "609.531 to 609.5316",
    "subdivision": ""
  }
]

Sponsors